Effect of recombinant bovine granulocyte colony-stimulating factor treatment during the peripartum period on postpartum diseases, reproductive performance, and milk production in Holstein cattle

被引:0
作者
Yanez, Uxia [1 ]
Alvarez, Jacobo [1 ]
Lorenzo, Guillermo [2 ]
Cainzos, Juan [3 ]
Dubuc, Jocelyn [4 ]
Becerra, Juan J. [1 ]
Herradon, Pedro G. [1 ]
Pena, Ana I. [1 ]
Quintela, Luis A. [1 ]
机构
[1] Univ Santiago de Compostela, Fac Vet Med, Dept Anim Pathol, Unit Reprod & Obstet, Avda Carballo Calero S-N, Lugo 27002, Spain
[2] Gando Nuevas Tecnol SL, Pl Espana 6, Ferrol 15403, Spain
[3] ABS Progenex, Calle Cal 34, Getafe 28906, Spain
[4] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 2M2, Canada
关键词
Pegbovigrastim; Transition period; Milk yield; Reproduction; Dairy cow; NONESTERIFIED FATTY-ACIDS; DAIRY; PEGBOVIGRASTIM; SAFETY; COWS;
D O I
10.1016/j.rvsc.2024.105368
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
To boost the immune function around parturition, recombinant bovine granulocyte colony-stimulating factor (rbG-CSF) has been used to increase the number of neutrophils. Therefore, the aim of this study was to quantify the effect of rbG-CSF administration on the incidence of postpartum pathologies, reproductive performance, and milk production during the first three months of lactation. A total of 199 Holstein cows from one herd were included and were randomly allocated into two groups: Control (n n = 103) and rbG-CSF (n n = 96). Cows in the rbG-CSF group received 2 doses of a rbG-CSF injectable formulation, one 7 days before the expected date of calving and the other within 24 h after calving. For 6 weeks following calving, animals were examined weekly to assess the presence of postpartum pathologies. Milk production, protein and fat content, and somatic cell count were determined monthly by the regional dairy herd improvement association. Data about the reproductive performance were collected from on-farm software. To analyse the effect of treatment on the incidence of postpartum pathologies, Pearson's chi 2 2 test and multivariable logistic regressions were performed. The effect on reproductive performance was analysed using Cox proportional hazard regression analysis for days open, binary logistic regression for first service conception rate and Oneway ANOVA test for the number of artificial inseminations. The effects of treatment on milk yield and milk composition were checked using GLM repeated measures analysis. No statistically significant differences were observed between treatment groups for any of the parameters evaluated. Only parity had a significant effect on days open and milk production (p p < 0.05). In conclusion, in the present study no evidence was found that rbG-CSF could have an effect on the reproductive and productive parameters evaluated.
引用
收藏
页数:6
相关论文
共 24 条
  • [1] Pegbovigrastim treatment resulted in an economic benefit in a large randomized clinical trial in grazing dairy cows
    Barca, Joaquin
    Schukken, Ynte H.
    Meikle, Ana
    Chilibroste, Pablo
    Bouman, Mette
    Hogeveen, H.
    [J]. JOURNAL OF DAIRY SCIENCE, 2023, 106 (02) : 1233 - 1245
  • [2] Effect of pegbovigrastim on fertility and culling in grazing dairy cows and its association with prepartum nonesterified fatty acids
    Barca, Joaquin
    Meikle, Ana
    Bouman, Mette
    Schukken, Ynte H.
    [J]. JOURNAL OF DAIRY SCIENCE, 2022, 105 (01) : 710 - 725
  • [3] Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows
    Barca, Joaquin
    Meikle, Ana
    Bouman, Mette
    Gnemmi, Giovanni
    Ruiz, Rodrigo
    Schukken, Ynte H.
    [J]. PLOS ONE, 2021, 16 (05):
  • [4] Efficacy and clinical safety of pegbovigrastim for preventing naturally occurring clinical mastitis in periparturient primiparous and multiparous cows on US commercial dairies
    Canning, Peter
    Hassfurther, Renee
    TerHune, Terry
    Rogers, Karen
    Abbott, Scott
    Kolb, David
    [J]. JOURNAL OF DAIRY SCIENCE, 2017, 100 (08) : 6504 - 6515
  • [5] Effect of dose rate and timing of administration of pegbovigrastim on white blood cell responses in grazing dairy cows
    Crookenden, M. A.
    Roche, J. R.
    Heiser, A.
    Kuhn-Sherlock, B.
    Higham, C. D.
    Phyn, C. V. C.
    Turner, S-A
    [J]. JOURNAL OF DAIRY SCIENCE, 2021, 104 (11) : 11955 - 11972
  • [6] Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
    Denis-Robichaud, J.
    Christophe, M.
    Roy, J. -P.
    Buczinski, S.
    Rousseau, M.
    Robichaud, M. Villettaz
    Dubuc, J.
    [J]. JDS COMMUNICATIONS, 2021, 2 (06): : 398 - 402
  • [7] Risk factors for postpartum uterine diseases in dairy cows
    Dubuc, J.
    Duffield, T. F.
    Leslie, K. E.
    Walton, J. S.
    LeBlanc, S. J.
    [J]. JOURNAL OF DAIRY SCIENCE, 2010, 93 (12) : 5764 - 5771
  • [8] Effect of recombinant bovine granulocyte colony-stimulating factor covalently bound to polyethylene glycol injection on neutrophil number and function in periparturient dairy cows
    Kimura, Kayoko
    Goff, Jesse P.
    Canning, Peter
    Wang, Chong
    Roth, James A.
    [J]. JOURNAL OF DAIRY SCIENCE, 2014, 97 (08) : 4842 - 4851
  • [9] Reproductive tract inflammatory disease in postpartum dairy cows
    LeBlanc, S. J.
    [J]. ANIMAL, 2014, 8 : 54 - 63
  • [10] Immunometabolic status and productive performance differences between periparturient Simmental and Holstein dairy cows in response to pegbovigrastim
    Lopreiato, V
    Minuti, A.
    Trimboli, F.
    Britti, D.
    Morittu, V. M.
    Cappelli, F. Piccioli
    Loor, J. J.
    Trevisi, E.
    [J]. JOURNAL OF DAIRY SCIENCE, 2019, 102 (10) : 9312 - 9327